Cerebral perfusion and automated individual analysis using spect among an obsessive-compulsive population [Perfusão cerebral e análise individual automatizada utilizando SPECT em uma população com transtorno obsessivo-compulsivo]
da Rocha E.T.,Hospital de Cancer Fundacao Pio XII |
da Rocha E.T.,Sao Paulo State University |
Buchpiguel C.A.,University of Sao Paulo |
Miguel E.C.,University of Sao Paulo |
And 2 more authors.
Jornal Brasileiro de Psiquiatria | Year: 2011
Objective: To make individual assessments using automated quantification methodology in order to screen for perfusion abnormalities in cerebral SPECT examinations among a sample of subjects with OCD. Methods: Statistical parametric mapping (SPM) was used to compare 26 brain SPECT images from patients with OCD individually with an image bank of 32 normal subjects, using the statistical threshold of p < 0.05 (corrected for multiple comparisons at the level of individual voxels or clusters). The maps were analyzed, and regions presenting voxels that remained above this threshold were sought. results: Six patients from a sample of 26 OCD images showed abnormalities at cluster or voxel level, considering the criteria described above, which represented 23.07%. However, seven images from the normal group of 32 were also indicated as cases of perfusional abnormality, representing 21.8% of the sample. Conclusion: The automated quantification method was not considered to be a useful tool for clinical practice, for analyses complementary to visual inspection.
Cavalcante S.P.,Hospital de Cancer Fundacao Pio XII |
Cavalcante S.P.,Sao Paulo State University |
de Almeida J.R.W.,Hospital de Cancer Fundacao Pio XII |
Clara C.A.,Hospital de Cancer Fundacao Pio XII |
And 6 more authors.
Experimental and Therapeutic Medicine | Year: 2010
Microvascular density (MVD) may be an additional prognostic marker for astrocytomas, but the heterogeneity of these tumors limits its use. Thus, imaging examinations such as SPECT-MIBI(2-methoxyisobutyl isonitrile) may take on an indirect role in astrocytoma evaluation. The aim of this study was to evaluate MVD in astrocytomas using immunohistochemistry with anti-CD34 monoclonal antibodies. The relationship between the immunohistochemical data and the parameters obtained from SPECT-MIBI was evaluated. This cross-sectional study evaluated 48 patients with brain tumors including low-grade astrocytomas (LGAs), anaplastic astrocytomas (AAs) and glioblastoma multiformes (GBMs). Patients had been admitted to the Hospital de Câncer de Barretos - Fundação Pio XII, and underwent brain SPECT-MIBI prior to any treatment. MVDwas determined under an optical microscope by counting microvessels on slides from each case. SPECT-MIBI images were analyzed visually and semiquantitatively. GBMs, AAs and LGAs represented 50, 16.7 and 33.3% of the total sample, respectively. There were 13 normal and 35 abnormal SPECT-MIBI images. Significant differences in MVD were found between AA and LGAcases (p=0.040), but not between normal and abnormal SPECT-MIBI. The mean counts from SPECT-MIBIwere not correlated with MVD. Among the GBM cases, there were no significant findings, except for an increased likelihood of abnormal histological test results. MVD was related to histological grade (in AA and LGA cases) but was not correlated with SPECT-MIBI.